CUPR
Cuprina Holdings (Cayman) Ltd - Class A (CUPR)
Healthcare • NASDAQ • $0.28+6.02%
- Symbol
- CUPR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $0.28
- Daily Change
- +6.02%
- Market Cap
- $6.00M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $9.50
- 52W Low
- $0.24
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Company websiteResearch CUPR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.